IFP Advisors’s Oncolytics Biotech ONCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$234 Buy
+350
New +$284 ﹤0.01% 4839
2025
Q4
– Sell
-100
Closed -$140 – 4995
2025
Q3
$140 Hold
100
– – ﹤0.01% 4471
2025
Q2
$77 Sell
100
-2,500
-96% -$1.32K ﹤0.01% 4758
2025
Q1
$1.43K Buy
2,600
+96
+4% +$70 ﹤0.01% 3251
2024
Q4
$2.29K Buy
2,504
+4
+0.2% +$4 ﹤0.01% 3056
2024
Q3
$2.18K Hold
2,500
– – ﹤0.01% 2894
2024
Q2
$2.48K Hold
2,500
– – ﹤0.01% 2764
2024
Q1
$2.65K Buy
+2,500
New +$2.79K ﹤0.01% 2622
2023
Q4
– Sell
-2,000
Closed -$4.36K – 3240
2023
Q3
$4.36K Buy
+2,000
New +$4.89K ﹤0.01% 2563
2023
Q1
– Sell
-20
Closed -$1K – 4114
2022
Q4
$1K Sell
20
-100
-83% -$152 ﹤0.01% 4423
2022
Q3
$1K Hold
120
– – ﹤0.01% 4626
2022
Q2
$1K Hold
120
– – ﹤0.01% 4403
2022
Q1
$1K Buy
+120
New +$201 ﹤0.01% 4401
2021
Q4
– Sell
-5,000
Closed -$10K – 3449
2021
Q3
$10K Hold
5,000
– – ﹤0.01% 2285
2021
Q2
$14K Hold
5,000
– – ﹤0.01% 2086
2021
Q1
$19K Hold
5,000
– – ﹤0.01% 1878
2020
Q4
$12K Hold
5,000
– – ﹤0.01% 1996
2020
Q3
$8K Hold
5,000
– – ﹤0.01% 1999
2020
Q2
$9K Hold
5,000
– – ﹤0.01% 1867
2020
Q1
$8K Hold
5,000
– – ﹤0.01% 1884
2019
Q4
$14K Buy
+5,000
New +$5.64K ﹤0.01% 1777

Other funds holding ONCY

IFP Advisors's ONCY Position: Q3 2026 in Review

IFP Advisors opened a new position in Oncolytics Biotech (ONCY) in Q3 2026: 350 shares worth $234. The stake represents ﹤0.01% of the portfolio and ranks #4839 among its holdings. This is a return to the name: IFP Advisors previously reported a position in ONCY as recently as Q3 2025.

IFP Advisors first reported a position in ONCY in Q4 2019 and has held it in 21 quarters since. The position peaked at $19K in Q1 2021. 12 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.

  • IFP Advisors held 350 shares of Oncolytics Biotech worth $234 as of Q3 2026.
  • Oncolytics Biotech was a new IFP Advisors position in Q3 2026.
  • Oncolytics Biotech made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4839 holding.
  • IFP Advisors first reported a position in Oncolytics Biotech in Q4 2019 and has held it in 21 quarters since.
  • IFP Advisors's Oncolytics Biotech position peaked at $19K in Q1 2021.
  • 12 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.